BioAdaptives Inc. announced the launch of MindnMemory, an advanced nootropic designed to enhance memory, mental focus, clarity and concentration. MindnMemory has a gradual, smooth onset and prolonged effect, maintaining beneficial effects without the sudden “high” and “crash” produced by caffeine and similar substances. The Company developed and test marketed this stimulant-free formulation, based on Traditional Chinese Medicine and Ayurvedic Culture, in response to the strong demand for a premium product that promotes optimal performance.

MindnMemory is designed to benefit not only those with age-related cognitive decline but also anyone, including e-Gamers, seeking peak perception, judgment, accuracy, reaction speed, and mood elevation. Ongoing research suggests that nootropics may also play a role in mental health. According to the World Health Organization, an estimated 300 million people are affected by depression globally, with women more affected than men.

Nootropics may be useful as supplements to deal with the symptoms of dementia and lesser forms of cognitive impairment, anxiety disorders, and other mental symptoms. Market research estimates global nootropic sales exceeded USD 10.5 billion in 2021, and that this nutraceutical segment is growing at a rate of up to 18% per year; current estimates call for global sales to approach $31 billion by 2029. On a cellular level, this benefit is supported by increased mitochondrial energy production, especially within the nervous, cardiovascular, and muscular systems. Consumers, including Seniors with or without cognitive issues, as well as, e-Gamers and those engaged in activities requiring prolonged periods of focus and intense concentration, report that the ingredients in MindnMemory help them achieve clear thinking, focus, more rapid recall, a sense of well-being, and resistance to mental and physical fatigue.